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FIGURE 4. Intraoperative photographs of the CorMatrix extracellular matrix tube at removal. A, Prolapsing CorMatrix tube. B, Resected CorMatrix tube
showing infection and degenerative changes.
Case Reportscontinuity is preserved.4 The failure that we observed in
this case may have been due to the weak antiinfective
property of CorMatrix or to its fragile nature when it is
in the body for certain duration. CorMatrix ECM’s resis-
tance to infection depends on angiogenesis and thus on
the patient’s own defense mechanisms. This may not be
adequate.
In conclusion, reconstruction of the entire tricuspid valve
with the ECM tube technique is efficacious in achieving
excellent valve function. The CorMatrix ECM, however,
may not be the ideal material to provide long-term durable
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a neonateLindsay A. Caldarone,a Christopher A. Caldarone, MD,b and Luca A. Vricella, MD,a Baltimore, Md, and
Toronto, Ontario, CanadaIn 1957, Darling and colleagues1 proposed a classification
scheme for total anomalous pulmonary venous connection
(TAPVC). According to this scheme, only 5% of patients
have ‘‘unusual’’ morphology, including mixed (type IV) or
nonconfluent veins. We present to our knowledge the first re-
ported case of retroesophageal pulmonary venous confluence.
CASE REPORT
A 2-month-old, 4.3-kg term infant with no previous car-
diac diagnosis was found cyanotic and listless and wasdiovascular Surgery c Volume 148, Number 2 e143
FIGURE 1. A, Schematic, axial rendition of retroesophageal total anom-
alous pulmonary venous connection. B, Schematic of situation after verti-
cal transection of the retroesophageal confluence. The right veins are
anastomosed to the posterior wall of the left atrium and the left veins to
the left atrial appendage. RA, Right atrium; LA, left atrium; LAA, left atrial
appendage; Esoph, esophagus; VV, vertical vein; RUPV, right upper pulmo-
nary vein; LUPV, left upper pulmonary vein; RLPV, right lower pulmonary
vein; LLPV, left lower pulmonary vein.
Case Reportstransported emergently to our institution, where a transtho-
racic echocardiogram revealed nonobstructed supracardiac
TAPVC with a vertical vein coursing posterior to the left
pulmonary artery and draining into the left brachiocephalic
vein. The patient was brought to the operating room with
the expectation that routine repair of supracardiac TAPVC
would be performed.
During surgery, however, the pulmonary venous conflu-
ence could not be located through the posterior pericar-
dium. After cardioplegic circulatory arrest was induced
with profound hypothermia, we attempted localization of
the confluence and proceeded to go as far as transecting
the inferior vena cava in the hope of finding the confluence
once the heart could be fully mobilized and the posterior
retrocardiac mediastinum completely exposed. The left
and right pulmonary veins could be identified in the respec-
tive pulmonary hila; when they were followed and carefully
dissected, however, they were noticed to be coursing poste-
rior to the esophagus (Figure 1, A). The esophagus was
mobilized in its mid portion, exposing the retroesophageal
confluence; the reconstruction was then undertaken by
vertically transecting the pulmonary venous confluence,
yielding 2 pulmonary venous ostia measuring approxi-
mately 5 to 6 mm in diameter. Each half of the divided
confluence was incised on its anterior aspect, and spatu-
lated anastomoses were constructed. The left venous
confluence was anastomosed directly onto the left atrial
appendage with a 7-0 running polypropylene suture (modi-
fied Warden procedure); the right atrium was incised trans-
versely across the interatrial septum and onto the posterior
left atrial wall. The right venous confluence was anasto-
mosed to the posterior transverse atriotomy (Figure 1, B),
and the atrial septal defect was closed with a patch of autol-
ogous pericardium. The postoperative course was unevent-
ful, and the infant was discharged home on the 10th
postoperative day. The child is alive and well with no resid-
ual pulmonary venous obstruction 3 years after the initial
operation.
DISCUSSION
The near totality of cases of TAPVC can be accounted
for within the classification scheme proposed in 1957 by
Darling and colleagues.1 According to this anatomic classi-
fication, only 5% of patients present with ‘‘unusual’’
morphology, including mixed (type IV) or nonconfluent
veins. Several unusual patterns have been described2,3; to
our knowledge, however, no case of retroesophageal
pulmonary venous confluence has thus far been reported.
In mixed types without obstruction or with complex
associated cardiac anomalies, it might be beneficial to
delineate further the anatomy with diagnostic imaging to aid
in operative planning. In the case reported here, the patient
had the condition correctly diagnosed as nonobstructed
supracardiac TAPVC, although the confluence’s relationshipe144 The Journal of Thoracic and Cardiovascular Surwith the esophagus could not be accurately delineated
by preoperative transthoracic echocardiography.
Intraoperatively, even transection of the inferior vena
cava did not aid in elucidating the anatomy, and only an-
tegrade dissection of the veins from the respective hila
was able to disclose the site of the obstruction behind
the esophagus. Once the venous pattern was identified
as joining behind the esophagus, two options were
feasible to obtain unobstructed pulmonary venous return.
The first would have been to perform a ‘‘sutureless
repair’’ by incising the veins and the overlying parietal
pericardium.4
The dissection around the esophagus had by this deci-
sion point been too extensive, leaving little pericardial
integrity around the veins to allow for a hemostatic repair.
We chose instead to anastomose the respective confluences
individually to the left atrial appendage and to the poste-
rior wall of the left atrium. Because of the size of the ves-
sels and the goal of minimizing the potential for late
stenosis, we spatulated the anastomoses to maximize their
linear length.gery c August 2014
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implantation within a dilated native right ventricular outflow tractFrances C. Travelli, MD,a Cynthia S. Herrington, MD,b and Frank F. Ing, MD,a Los Angeles, CalifSince the Food and Drug Administration approval of the
Melody transcatheter pulmonary valve (Medtronic Inc,
Minneapolis, Minn) in 2010, multiple reports of its use to
treat dysfunctional right ventricle-to-pulmonary artery con-
duits have been published.1,2 However, use of this valve is
limited to 16- to 22-mm diameter conduits or bioprosthetic
valves.1 The Melody valve is not recommended for native
right ventricular outflow tracts (RVOTs) because of its gen-
eral dilated anatomy and high compliance of the native tis-
sue, rendering a high risk of device malposition or
embolization. We report a novel hybrid technique of Mel-
ody valve implantation within a dilated native RVOT.
CLINICAL SUMMARY
A 17-year-old male patient with tetralogy of Fallot status
post-transannular patch repair at age 1 month presented
with severe pulmonary insufficiency and increasing exer-
cise intolerance. Cardiac magnetic resonance imaging
showed a markedly dilated right ventricle, right ventricular
indexed end-diastolic volume 194 mL/m2, regurgitant frac-
tion 50%, and preserved biventricular function. The dilated
native RVOT diameter was 24 mm. Because of mild devel-
opmental delay resulting from a cerebral infarct after his
initial tetralogy of Fallot repair, the decision was made toavoid the risks of cardiopulmonary bypass and proceed
with the hybrid approach for Melody valve implantation.
After a midline sternotomy and exposure of the RVOT, a
12 mm in width short ‘‘tube’’ was cut from a 22-mm poly-
tetrafluoroethylene graft (Gore-Tex,WLGore &Associates
Inc, Flagstaff, Ariz). This tube was then cut and wrapped
around the main pulmonary artery (MPA) just above the
pulmonary annulus to ‘‘restrict’’ the MPA diameter to 22
mm (Figure 1). The width and location of the tube were
carefully selected by dissecting the MPA from the aorta
and measuring the distance from the pulmonary annulus
to the take-off of the right pulmonary artery. The coronaryFIGURE 1. A, A 22-mm polytetrafluoroethylene tube. B, A 12-mmwidth
short tube cut and opened. C, The tube is placed around the RVOT (blue
arrows) to be used as the landing zone for the Melody valve (Medtronic
Inc, Minneapolis, Minn).
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